Andersons pediatric cardiology 344
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.49 KB, 3 trang )
ApplPhysiol.1975;39(3):453–456.
132.DeBuystJ,RakzaT,PennaforteT,Johansson
AB,StormeL.Hemodynamiceffectsoffluid
restrictioninpreterminfantswithsignificant
patentductusarteriosus.JPediatr.
2012;161(3):404–408.
133.GreenTP,ThompsonTR,JohnsonDE,LockJE.
Diuresisandpulmonaryfunctioninpremature
infantswithrespiratorydistresssyndrome.J
Pediatr.1983;103(4):618–623.
134.GreenTP,ThompsonTR,JohnsonDE,LockJE.
Furosemidepromotespatentductusarteriosusin
prematureinfantswiththerespiratory-distress
syndrome.NEnglJMed.1983;308(13):743–
748.
135.WongR.Maintenancedietandtheeffectsof
furosemideonhamsters.AmJPsychol.
1981;94(2):339–354.
136.BrionLP,CampbellDE.Furosemidein
indomethacin-treatedinfants–systematicreview
andmeta-analysis.Pediatricnephrology.
1999;13(3):212–218.
137.HammermanC,GlaserJ,KaplanM,etal.
Indomethacintocolysisincreasespostnatal
patentductusarteriosusseverity.Pediatrics.
1998;102(5):E56.
138.OhlssonA,WaliaR,ShahS.Ibuprofenforthe
treatmentofpatentductusarteriosusinpreterm
and/orlowbirthweightinfants.Cochrane
DatabaseSystRev.2008;(1)[CD003481].
139.LinYJ,ChenCM,RehanVK,etal.Randomized
trialtocomparerenalfunctionandductal
responsebetweenindomethacinandibuprofen
treatmentinextremelylowbirthweightinfants.
Neonatology.2017;111(3):195–202.
140.ClymanRI.Recommendationsforthepostnatal
useofindomethacin:ananalysisoffourseparate
treatmentstrategies.JPediatr.1996;128(5Pt
1):601–607.
141.TammelaO,OjalaR,IivainenT,etal.Short
versusprolongedindomethacintherapyfor
patentductusarteriosusinpreterminfants.J
Pediatr.1999;134(5):552–557.
142.SchmidtB,DavisP,ModdemannD,etal.Longtermeffectsofindomethacinprophylaxisin
extremely-low-birth-weightinfants.NEnglJ
Med.2001;344(26):1966–1972.
143.KnightDB.Thetreatmentofpatentductus
arteriosusinpreterminfants.Areviewand
overviewofrandomizedtrials.Seminarsin
neonatology:SN.2001;6(1):63–73.
144.FowliePW,DavisPG,McGuireW.Prophylactic
intravenousindomethacinforpreventing
mortalityandmorbidityinpreterminfants.
CochraneDatabaseSystRev.2010;(7)
[CD000174].
145.GournayV,SavagnerC,ThiriezG,KusterA,
RozeJC.Pulmonaryhypertensionafter
ibuprofenprophylaxisinverypreterminfants.
Lancet(London,England).
2002;359(9316):1486–1488.
146.KluckowM,JefferyM,GillA,EvansN.A
randomisedplacebo-controlledtrialofearly
treatmentofthepatentductusarteriosus.Arch
DisChildFetalNeonatalEd.2014;99(2):F99–
F104.
147.ThomasRL,ParkerGC,VanOvermeireB,
ArandaJV.Ameta-analysisofibuprofenversus
indomethacinforclosureofpatentductus
arteriosus.EurJPediatr.2005;164(3):135–140.
148.VanOvermeireB,SmetsK,LecoutereD,etal.A
comparisonofibuprofenandindomethacinfor
closureofpatentductusarteriosus.NEnglJ
Med.2000;343(10):674–681.
149.PezzatiM,VangiV,BiagiottiR,etal.Effectsof
indomethacinandibuprofenonmesentericand
renalbloodflowinpreterminfantswithpatent
ductusarteriosus.JPediatr.1999;135(6):733–
738.
150.PatelJ,MarksKA,RobertsI,AzzopardiD,
EdwardsAD.Ibuprofentreatmentofpatent
